Inactive Instrument

MAXO CAP Stock

Equities

JMAC

US57778T1060

Dynamic Chart
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Maxpro Capital Acquisition Corp.(NasdaqGM:JMAC) dropped from NASDAQ Composite Index CI
Apollomics, Inc. completed the acquisition of Maxpro Capital Acquisition Corp. from MP One Investment LLC and others in a reverse merger. CI
Maxpro Capital Acquisition Extends Deadline to Complete Business Combination MT
Maxpro Capital Acquisition Corp. announced that it has received $0.5 million in funding from MP One Investment LLC CI
Apollomics Gets Orphan Drug Designation for Vebreltinib to Treat Lung Cancer MT
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Apollomics to be Listed on Nasdaq Through Business Combination With Maxpro Capital Acquisition MT
Apollomics, Inc. agreed to acquire Maxpro Capital Acquisition Corp. from MP One Investment LLC and others for approximately $910 million in a reverse merger transaction. CI
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Maxpro Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Certain Class B Common Stock of Maxpro Capital Acquisition Corp. are subject to a Lock-Up Agreement Ending on 5-APR-2022. CI
Maxpro Capital Acquisition Corp.(NasdaqGM:JMAC) added to NASDAQ Composite Index CI
Maxpro Capital Acquisition Corp. has completed an IPO in the amount of $90 million. CI
Maxpro Capital Acquisition Corp. has filed an IPO in the amount of $100 million. CI
More news
Maxpro Capital Acquisition Corp, formerly Jade Mountain Acquisition Corp, is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company's acquisitions are focused on companies in the healthcare technology sector in which its management team has experiences. The Company plans to explore industries include, but are not limited to, the healthcare and technology industries, particularly in the biotechnology and pharmaceutical industries.
Sector
-
More about the company